Aviva PLC trimmed its position in Perrigo Company PLC (NYSE:PRGO) by 24.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 47,905 shares of the company’s stock after selling 15,456 shares during the period. Aviva PLC’s holdings in Perrigo were worth $1,856,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Standard Life Aberdeen plc lifted its stake in shares of Perrigo by 1.0% in the 4th quarter. Standard Life Aberdeen plc now owns 254,909 shares of the company’s stock valued at $10,099,000 after acquiring an additional 2,498 shares during the last quarter. Parametrica Management Ltd bought a new position in shares of Perrigo in the 4th quarter valued at $224,000. Accident Compensation Corp bought a new position in Perrigo during the 4th quarter worth $355,000. Mn Services Vermogensbeheer B.V. raised its position in Perrigo by 4.7% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 22,068 shares of the company’s stock worth $748,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Advisor Group Inc. raised its position in Perrigo by 822.2% during the 4th quarter. Advisor Group Inc. now owns 1,079 shares of the company’s stock worth $41,000 after purchasing an additional 962 shares during the last quarter. Institutional investors own 84.53% of the company’s stock.
Shares of Perrigo stock opened at $47.36 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.89 and a quick ratio of 1.32. Perrigo Company PLC has a 1-year low of $36.28 and a 1-year high of $86.33. The stock has a market cap of $6.49 billion, a price-to-earnings ratio of 10.41, a price-to-earnings-growth ratio of 2.07 and a beta of 1.31.
Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, February 27th. The company reported $0.97 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.00 by ($0.03). Perrigo had a return on equity of 10.74% and a net margin of 2.77%. The business had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.18 billion. During the same quarter in the previous year, the business posted $1.28 earnings per share. The business’s revenue was down 6.5% on a year-over-year basis. On average, sell-side analysts forecast that Perrigo Company PLC will post 4.47 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 19th. Shareholders of record on Friday, March 1st will be issued a dividend of $0.19 per share. The ex-dividend date is Thursday, February 28th. This represents a $0.76 dividend on an annualized basis and a yield of 1.60%. Perrigo’s payout ratio is currently 16.70%.
Several research analysts recently issued reports on PRGO shares. Cantor Fitzgerald set a $107.00 target price on Perrigo and gave the stock a “buy prgo” rating in a research report on Thursday, December 20th. Royal Bank of Canada set a $50.00 target price on Perrigo and gave the stock a “hold” rating in a research report on Friday, January 4th. ValuEngine lowered Perrigo from a “hold” rating to a “sell” rating in a research report on Thursday, December 20th. Morgan Stanley set a $67.00 target price on Perrigo and gave the stock a “hold” rating in a research report on Sunday, December 30th. Finally, Wells Fargo & Co lowered their target price on Perrigo from $64.00 to $46.00 and set a “market perform” rating for the company in a research report on Friday, December 21st. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $77.29.
TRADEMARK VIOLATION WARNING: “Aviva PLC Reduces Stake in Perrigo Company PLC (PRGO)” was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.thelincolnianonline.com/2019/03/15/aviva-plc-reduces-stake-in-perrigo-company-plc-prgo.html.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Article: Understanding Average Daily Trade Volume
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.